McDonald E, Pittet LF, Bonten M, Byrne A, Campbell J, Croda J, Dalcolmo M, Davidson AJ, Dos Santos G, Gardiner K, Gwee A, Jardim B, Lacerda M, Lucas M, Lynn DJ, Manning L, Marshall H, Perrett KP, Prat-Aymerich C, Puga MAM, Richmond P, Rodríguez-Baño J, Wadia U, Warris A, Wood N, Curtis N, Messina NL; BRACE Trial Consortium Group Full text COVID-19 Special risk groups Vaccine safety Vaccine trials 2026 BMC Infectious Diseases 2026;26:974. doi: 10.1186/s12879-026-13128-6